What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.97%Below 5Y avg (3.03%)
Annual Rate
JPY 22.00Paid semi-annual
Payout Ratio
27.0%Sustainable
Last Ex-Dividend
Mar 30, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
51.42BJPY
323.31M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
27.40x
vs Medical Care Facilities peers
Updated Aug 21, 2026
Revenue (TTM)
141.14BJPY
887.46M · vs all stocks (USD)
Updated Aug 21, 2026
Profit Margin
2.65%
vs Medical Care Facilities peers
Updated Aug 21, 2026
Beta
0.3880x
vs all stocks
Updated Aug 21, 2026
52-Week Change
130.04%
vs all stocks
Updated Aug 21, 2026
Forward Annual Dividend Yield
1.97%
vs all stocks
Updated Aug 21, 2026
Market Capitalization
51.42BJPY
323.31M · vs all stocks (USD)
Updated Aug 21, 2026
Enterprise Value
107.14BJPY
673.65M · vs all stocks (USD)
Updated Aug 21, 2026
Trailing P/E
27.40x
vs Medical Care Facilities peers
Updated Aug 21, 2026
Forward P/E
26.12x
vs Medical Care Facilities peers
Updated Aug 21, 2026
Price to Sales (TTM)
0.7173x
vs Medical Care Facilities peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 0.36×.Updated Aug 21, 2026
Price to Book (MRQ)
4.32x
vs Medical Care Facilities peers
Updated Aug 21, 2026
Enterprise to Revenue
0.7590x
vs Medical Care Facilities peers
Updated Aug 21, 2026
Enterprise to EBITDA
10.26x
vs Medical Care Facilities peers
Updated Aug 21, 2026
Profit Margin
2.65%
vs Medical Care Facilities peers
Updated Aug 21, 2026
Operating Margin
5.17%
vs Medical Care Facilities peers
Updated Aug 21, 2026
Return on Assets (TTM)
6.74%
vs Medical Care Facilities peers
Updated Aug 21, 2026
Return on Equity (TTM)
16.21%
vs Medical Care Facilities peers
Updated Aug 21, 2026
Revenue (TTM)
141.14BJPY
887.46M · vs all stocks (USD)
Updated Aug 21, 2026
Revenue per Share (TTM)
1.54KJPYUpdated Aug 21, 2026
Quarterly Revenue Growth
3.00%
vs Medical Care Facilities peers
Updated Aug 21, 2026
Gross Profit (TTM)
23.29BJPY
146.45M · vs all stocks (USD)
Updated Aug 21, 2026
EBITDA (TTM)
10.64BJPY
66.87M · vs all stocks (USD)
Updated Aug 21, 2026
Net Income (TTM)
3.74BJPY
23.52M · vs all stocks (USD)
Updated Aug 21, 2026
Quarterly Earnings Growth (YoY)
-74.40%
vs Medical Care Facilities peers
Updated Aug 21, 2026
Operating Cash Flow (TTM)
6.82BJPY
42.87M · vs all stocks (USD)
Updated Aug 21, 2026
Levered Free Cash Flow (TTM)
6.09BJPY
38.32M · vs all stocks (USD)
Updated Aug 21, 2026
Forward Annual Dividend Rate
22.00JPYUpdated Aug 21, 2026
Forward Annual Dividend Yield
1.97%
vs all stocks
Updated Aug 21, 2026
Trailing Annual Dividend Rate
21.00JPYUpdated Aug 21, 2026
Trailing Annual Dividend Yield
1.88%
vs all stocks
Updated Aug 21, 2026
5-Year Average Dividend Yield
3.03%
vs all stocks
Updated Aug 21, 2026
Payout Ratio
26.95%
vs Medical Care Facilities peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 51.46%.Updated Aug 21, 2026
Revenue
141.14BJPYFY2026 · Mar 31, 2026
Cost of Goods Sold
117.85BJPYFY2026 · Mar 31, 2026
Gross Profit
23.29BJPYFY2026 · Mar 31, 2026
Operating Income
7.35BJPY
46.19M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Pre-tax Income
6.36BJPYFY2026 · Mar 31, 2026
Income Tax Expense
2.62BJPYFY2026 · Mar 31, 2026
Net Income
3.74BJPYFY2026 · Mar 31, 2026
EBIT
6.61BJPYFY2026 · Mar 31, 2026
EBITDA (Income Statement)
10.64BJPYFY2026 · Mar 31, 2026
Non-operating Interest Expense
256.00MJPYFY2026 · Mar 31, 2026
EPS (Basic)
40.82JPYFY2026 · Mar 31, 2026
EPS (Diluted)
40.82JPYFY2026 · Mar 31, 2026
Basic Shares Outstanding
91.64MSharesFY2026 · Mar 31, 2026
Diluted Shares Outstanding
91.64MSharesFY2026 · Mar 31, 2026
Preferred Stock Dividends
0.00JPYFY2026 · Mar 31, 2026
Operating Cash Flow
5.82BJPYFY2026 · Mar 31, 2026
Free Cash Flow
5.52BJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents (End of Period)
12.21BJPYFY2026 · Mar 31, 2026
Starting Profit (CF Statement)
6.36BJPYFY2026 · Mar 31, 2026
Other Non-cash Items
169.00MJPYFY2026 · Mar 31, 2026
Change in Accounts Receivable (CF)
-557.00MJPYFY2026 · Mar 31, 2026
Change in Other Assets/Liabilities
-153.00MJPYFY2026 · Mar 31, 2026
Capital Expenditures
-297.00MJPYFY2026 · Mar 31, 2026
Net Intangibles (CF)
-486.00MJPYFY2026 · Mar 31, 2026
Sale of Investments
310.00MJPYFY2026 · Mar 31, 2026
Other Investing Activity
-75.00MJPYFY2026 · Mar 31, 2026
Net Investing Cash Flow
-62.00MJPYFY2026 · Mar 31, 2026
Long-term Debt Payments
-4.78BJPYFY2026 · Mar 31, 2026
Common Stock Repurchase
-1.13BJPYFY2026 · Mar 31, 2026
Common Dividends Paid
-1.93BJPYFY2026 · Mar 31, 2026
Other Financing Charges
-3.00MJPYFY2026 · Mar 31, 2026
Net Financing Cash Flow
-7.84BJPYFY2026 · Mar 31, 2026
Shares Outstanding
90.55MSharesUpdated Aug 21, 2026
Float Shares
90.55MSharesUpdated Aug 21, 2026
% Held by Insiders
87.18%
vs all stocks
Updated Aug 21, 2026
% Held by Institutions
4.84%
vs all stocks
Updated Aug 21, 2026
Total Cash (MRQ)
12.21BJPY
76.78M · vs all stocks (USD)
Updated Aug 21, 2026
Total Cash per Share (MRQ)
134.86JPYUpdated Aug 21, 2026
Total Debt (MRQ)
18.12BJPY
113.91M · vs all stocks (USD)
Updated Aug 21, 2026
Total Debt to Equity (MRQ)
0.7722x
vs Medical Care Facilities peers
Updated Aug 21, 2026
Current Ratio (MRQ)
1.34x
vs Medical Care Facilities peers
Updated Aug 21, 2026
Book Value per Share (MRQ)
259.07JPYUpdated Aug 21, 2026
Total Assets
66.20BJPY
416.27M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Total Current Assets
30.27BJPYFY2026 · Mar 31, 2026
Total Liabilities
42.75BJPYFY2026 · Mar 31, 2026
Total Non-current Assets
35.94BJPYFY2026 · Mar 31, 2026
Total Non-current Liabilities
20.15BJPYFY2026 · Mar 31, 2026
Total Current Liabilities
22.61BJPYFY2026 · Mar 31, 2026
Cash & Cash Equivalents
12.21BJPYFY2026 · Mar 31, 2026
Accounts Receivable
15.54BJPYFY2026 · Mar 31, 2026
Inventory
116.00MJPYFY2026 · Mar 31, 2026
Short-term Debt
4.78BJPYFY2026 · Mar 31, 2026
Other Current Liabilities
1.03BJPYFY2026 · Mar 31, 2026
Long-term Debt
13.33BJPYFY2026 · Mar 31, 2026
Other Non-current Liabilities
1.66BJPYFY2026 · Mar 31, 2026
Common Stock (Book)
686.00MJPYFY2026 · Mar 31, 2026
Retained Earnings
19.55BJPYFY2026 · Mar 31, 2026
Total Shareholders' Equity
23.46BJPY
147.49M · vs all stocks (USD)
FY2026 · Mar 31, 2026
Treasury Stock
2.50BJPYFY2026 · Mar 31, 2026
52-Week Low
475.00JPYUpdated Aug 21, 2026
52-Week High
1.12KJPYUpdated Aug 21, 2026
52-Week Change
130.04%
vs all stocks
Updated Aug 21, 2026
Beta
0.3880x
vs all stocks
Updated Aug 21, 2026
50-Day MA
1.11KJPYUpdated Aug 21, 2026
200-Day MA
938.90JPYUpdated Aug 21, 2026
Avg 10-Day Volume
68.61KSharesUpdated Aug 21, 2026
Avg 30-Day Volume
81.51KSharesUpdated Aug 21, 2026
Diluted EPS (TTM)
40.81JPYUpdated Aug 21, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Its free cash flow is large next to assets and equity, and more of its operating cash reaches it than in its industry.
Reads
Is this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 3.73: safe zoneNotable
Altman Z-Score: 3.73
High earnings qualityNotable
Earnings Quality Score: 0.95
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Revenue is $887.46M, above the global median of $520.53MNotable